Market Prices Or Political Expediency? Amgen’s US Lawsuit Seen As Litmus Test
US States Cast In The Role Of ‘Laboratory For Health Policy Change’
As the US struggles to contain the cost of prescription medicines, a growing number of state governments are trying to take matters into their own hands and believe prescription drug affordability boards could be the answer.
